Team

Studium der Humanmedizin

• von 1989 - 1995 an der Albert-Einstein Universität Ulm
• von 1995 - 1996 an der Ludwig-Maximilian Universität München

Ärztliche Prüfung

• 1996
• Promotion an der RWTH Aachen 1997

AIP

• vom 01.01.1997- 30.06.1998 in der Klinik für Diagnostische Radiologie und Neuroradiologie des Klinikums Augsburg

Approbation

• 01.07.1998

Facharztausbildung

• vom 11.7.1998 - 31.12.1999 in der Klinik und Poliklinik für Strahlentherapie und Radioonkologie der LMU München
• vom 01.01.2000 - 30.04.2000 in der Klinik für Diagnostische Radiologie und Neuroradiologie des Klinikums Augsburg
• vom 11.05.2000 - 30.10.2003 in der Strahlenklinik des Klinikums Augsburg

Facharztanerkennung

• 15.10 2003
• seit 01.11.03 als Facharzt in der Strahlenklinik des Klinikums Augsburg
• seit 01.07.06 Oberarzt
• seit 2007 Leitung des IORT Programms am Klinikum Augsburg
• seit 2008 Aufbau Leitung Radiochirurgie/SXRT am Klinikum Augsburg
• seit 01.05.09 Ltd. Oberarzt bestellt

Wissenschaftliche Schwerpunkte

• Stereotaxie
• IORT
• Radioimmunologie

1. K.-H. Kahl, N. Balagiannis, M. Höck, S. Schill, Z. Roushan, E. Shiban, H. Müller, U. Grossert, I. Konietzko, B. Sommer, C.J. Maurer, A. Berlis, V. Heidecke, T. Janzen, G. Stüben, Intraoperative radiotherapy with low-energy x-rays after neurosurgical resection of brain metastases—an Augsburg University Medical Center experience, Strahlenther Onkol. (2021). https://doi.org/10.1007/s00066-021-01831-z.
2. D. Buergy, F. Würschmidt, E. Gkika, J. Hörner‐Rieber, S. Knippen, S. Gerum, P. Balermpas, C. Henkenberens, T. Voglhuber, C. Kornhuber, S. Barczyk, B. Röper, A. Rashid, O. Blanck, A. Wittig, H. Herold, T.B. Brunner, R.J. Klement, K.H. Kahl, I.F. Ciernik, A. Ottinger, V. Izaguirre, F. Putz, L. König, M. Hoffmann, S.E. Combs, M. Guckenberger, J. Boda‐Heggemann, Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis, Int. J. Cancer. 149 (2021) 358–370. https://doi.org/10.1002/ijc.33546.
3. C.P. Cifarelli, S. Brehmer, J.A. Vargo, J.D. Hack, K.H. Kahl, G. Sarria-Vargas, F.A. Giordano, Intraoperative radiotherapy (IORT) for surgically resected brain metastases: outcome analysis of an international cooperative study, J Neurooncol. 145 (2019) 391–397. https://doi.org/10.1007/s11060-019-03309-6.
4. C. Cifarelli, J.A. Vargo, J. Hack, K.H. Kahl, S. Brehmer, G. Sarria, F. Giordano, RADI-20. RETROSPECTIVE OUTCOME ANALYSIS OF INTRAOPERATIVE RADIOTHERAPY (IORT) FOR SURGICALLY RESECTED BRAIN METASTASES: AN INTERNATIONAL COOPERATIVE STUDY., Neuro-Oncology Advances. 1 (2019) i25–i25. https://doi.org/10.1093/noajnl/vdz014.112.
5. M. Guckenberger, R.J. Klement, M. Allgäuer, N. Andratschke, O. Blanck, J. Boda-Heggemann, K. Dieckmann, M. Duma, I. Ernst, U. Ganswindt, P. Hass, C. Henkenberens, R. Holy, D. Imhoff, H.K. Kahl, R. Krempien, F. Lohaus, U. Nestle, M. Nevinny-Stickel, C. Petersen, S. Semrau, J. Streblow, T.G. Wendt, A. Wittig, M. Flentje, F. Sterzing, Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy, Radiotherapy and Oncology. 118 (2016) 485–491. https://doi.org/10.1016/j.radonc.2015.09.008.
6. J. Hoerner-Rieber, M. Duma, O. Blanck, G. Hildebrandt, A. Wittig, F. Lohaus, M. Flentje, F. Mantel, R. Krempien, M.J. Eble, K.H. Kahl, J. Boda-Heggemann, S. Rieken, M. Guckenberger, Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma—a multicenter analysis of the German working group “Stereotactic Radiotherapy,” J. Thorac. Dis. 9 (2017) 4512 4522. https://doi.org/10.21037/jtd.2017.10.108.
7. J. Hörner-Rieber, D. Bernhardt, O. Blanck, M. Duma, H.Th. Eich, S. Gerum, E. Gkika, P. Hass, C. Henkenberens, H.-U. Herold, G. Hildebrandt, D. Imhoff, H. Kahl, S. Janssen, K. Jurianz, R. Krempien, S.F. Lautenschläger, F. Lohaus, A.-C. Mueller, C. Petersen, I. Sackerer, D. Scafa, E. Schrade, L. Uhlmann, A. Wittig, M. Guckenberger, Long-term Follow-up and Patterns of Recurrence of Patients With Oligometastatic NSCLC Treated With Pulmonary SBRT, Clinical Lung Cancer. 20 (2019) e667–e677. https://doi.org/10.1016/j.cllc.2019.06.024.
8. R.J. Klement, J. Hoerner-Rieber, S. Adebahr, N. Andratschke, O. Blanck, J. Boda-Heggemann, M. Duma, M.J. Eble, H.C. Eich, M. Flentje, S. Gerum, P. Hass, C. Henkenberens, G. Hildebrandt, D. Imhoff, K.H. Kahl, N.D. Klass, R. Krempien, F. Lohaus, C. Petersen, E. Schrade, T.G. Wendt, A. Wittig, M. Guckenberger, Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: Analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacy, Radiotherapy and Oncology. 127 (2018) 246–252. https://doi.org/10.1016/j.radonc.2018.02.016.
9. R.J. Klement, N. Abbasi-Senger, S. Adebahr, H. Alheid, M. Allgaeuer, G. Becker, O. Blanck, J. Boda-Heggemann, T. Brunner, M. Duma, M.J. Eble, I. Ernst, S. Gerum, D. Habermehl, P. Hass, C. Henkenberens, G. Hildebrandt, D. Imhoff, H. Kahl, N.D. Klass, R. Krempien, V. Lewitzki, F. Lohaus, C. Ostheimer, A. Papachristofilou, C. Petersen, J. Rieber, T. Schneider, E. Schrade, R. Semrau, S. Wachter, A. Wittig, M. Guckenberger, N. Andratschke, The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases, BMC Cancer. 19 (2019) 173. https://doi.org/10.1186/s12885-019-5362-5.
10. R.J. Klement, M. Allgäuer, N. Andratschke, O. Blanck, J. Boda-Heggemann, K. Dieckmann, M. Duma, I. Ernst, M. Flentje, U. Ganswindt, P. Hass, C. Henkenberens, D. Imhoff, H.K. Kahl, R. Krempien, F. Lohaus, U. Nestle, M. Nevinny-Stickel, C. Petersen, V. Schmitt, S. Semrau, F. Sterzing, J. Streblow, T.G. Wendt, A. Wittig, M. Guckenberger, Bayesian Cure Rate Modeling of Local Tumor Control: Evaluation in Stereotactic Body Radiation Therapy for Pulmonary Metastases, International Journal of Radiation Oncology*Biology*Physics. 94 (2016) 841–849. https://doi.org/10.1016/j.ijrobp.2015.12.004.
11. S.G.C. Kroeze, J. Schaule, C. Fritz, D. Kaul, O. Blanck, K.H. Kahl, F. Roeder, S. Siva, J.J.C. Verhoeff, S. Adebahr, M.M. Schymalla, M. Glatzer, M. Szuecs, M. Geier, G. Skazikis, I. Sackerer, F. Lohaus, F. Eckert, M. Guckenberger, Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the ‘TOaSTT’ database, Radiat Oncol. 16 (2021) 4. https://doi.org/10.1186/s13014-020-01730-0.
12. S.G.C. Kroeze, C. Fritz, J. Schaule, S. Siva, K.H. Kahl, N. Sundahl, O. Blanck, D. Kaul, S. Adebahr, J.J.C. Verhoeff, G. Skazikis, F. Roeder, M. Geier, F. Eckert, M. Guckenberger, Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma: Metastasis directed radiotherapy for RCC, BJU Int. (2020). https://doi.org/10.1111/bju.15284.
13. S.G.C. Kroeze, C. Fritz, J. Schaule, S. Siva, K.H. Kahl, N. Sundahl, O. Blanck, D. Kaul, S. Adebahr, J.J.C. Verhoeff, G. Skazikis, F. Roeder, M. Geier, F. Eckert, M. Guckenberger, Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma, BJU Int. 127 (2021) 703–711. https://doi.org/10.1111/bju.15284.
14. P. Mayr, B. Martin, V. Fries, R. Claus, M. Anthuber, H. Messmann, G. Schenkirsch, V. Blodow, K.H. Kahl, G. Stüben, Neoadjuvant and Definitive Radiochemotherapeutic Approaches in Esophageal Cancer: A Retrospective Evaluation of 122 Cases in Daily Clinical Routine, Oncol Res Treat. 43 (2020) 372–379. https://doi.org/10.1159/000507737.
15. J. Rieber, N. Abbassi-Senger, S. Adebahr, N. Andratschke, O. Blanck, M. Duma, M.J. Eble, I. Ernst, M. Flentje, S. Gerum, P. Hass, C. Henkenberens, G. Hildebrandt, D. Imhoff, H. Kahl, N.D. Klass, R. Krempien, F. Lohaus, F. Lohr, C. Petersen, E. Schrade, J. Streblow, L. Uhlmann, A. Wittig, F. Sterzing, M. Guckenberger, Influence of Institutional Experience and Technological Advances on Outcome of Stereotactic Body Radiation Therapy for Oligometastatic Lung Disease, International Journal of Radiation Oncology*Biology*Physics. 98 (2017) 511-520. https://doi.org/10.1016/j.ijrobp.2016.09.026.
16. J. Rieber, J. Streblow, L. Uhlmann, M. Flentje, M. Duma, I. Ernst, O. Blanck, A. Wittig, J. Boda-Heggemann, R. Krempien, F. Lohaus, N.D. Klass, M.J. Eble, D. Imhoff, H. Kahl, C. Petersen, S. Gerum, C. Henkenberens, S. Adebahr, P. Hass, E. Schrade, T.G. Wendt, G. Hildebrandt, N. Andratschke, F. Sterzing, M. Guckenberger, Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases—A pooled analysis of the German working group “stereotactic radiotherapy,” Lung Cancer. 97 (2016) 51–58. https://doi.org/10.1016/j.lungcan.2016.04.012.
17. J. Schaule, S.G.C. Kroeze, O. Blanck, S. Stera, K.H. Kahl, F. Roeder, S.E. Combs, D. Kaul, A. Claes, M.M. Schymalla, S. Adebahr, F. Eckert, F. Lohaus, N. Abbasi-Senger, G. Henke, M. Szuecs, M. Geier, N. Sundahl, D. Buergy, R. Dummer, M. Guckenberger, Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score, Radiat Oncol. 15 (2020) 280. https://doi.org/10.1186/s13014-020-01708-y.
18.  J. Schaule, S.G.C. Kroeze, O. Blanck, S. Stera, K.H. Kahl, F. Roeder, S.E. Combs, D. Kaul, A. Claes, M.M. Schymalla, S. Adebahr, F. Eckert, F. Lohaus, N. Abbasi-Senger, G. Henke, M. Szuecs, M. Geier, N. Sundahl, D. Buergy, R. Dummer, M. Guckenberger, Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score, Radiat Oncol. 15 (2020) 135. https://doi.org/10.1186/s13014-020-01558-8.
19.  S. Tanadini-Lang, J. Rieber, A.R. Filippi, M.M. Fode, J. Streblow, S. Adebahr, N. Andratschke, O. Blanck, J. Boda-Heggemann, M. Duma, M.J. Eble, I. Ernst, M. Flentje, S. Gerum, P. Hass, C. Henkenberens, G. Hildebrandt, D. Imhoff, H. Kahl, N.D. Klass, R. Krempien, F. Lohaus, C. Petersen, E. Schrade, T.G. Wendt, A. Wittig, M. Høyer, U. Ricardi, F. Sterzing, M. Guckenberger, Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease, Radiotherapy and Oncology. 123 (2017) 182–188. https://doi.org/10.1016/j.radonc.2017.01.003.
20.  S.G.C. Kroeze, C. Fritz, J. Schaule, O. Blanck, K.H. Kahl, D. Kaul, S. Siva, S. Gerum, A. Claes, N. Sundahl, S. Adebahr, S. Stera, M.M. Schymalla, N. Abbasi-Senger, D. Buergy, M. Geier, M. Szuecs, F. Lohaus, G. Henke, S.E. Combs, M. Guckenberger, Continued versus Interrupted Targeted Therapy during Metastasis-Directed Stereotactic Radiotherapy: A Retrospective Multi-Center Safety and Efficacy Analysis, Cancers. 13 (2021) 4780. https://doi.org/10.3390/cancers13194780.